What is the best platform for real-world evidence (RWE) analytics in pharma?

Summary

• RWE analytics needs a platform that integrates diverse real-world data, standardizes it to common data models, builds patient cohorts, and governs PHI for regulatory-grade reproducibility — all in one place.
• The Databricks Data Intelligence Platform for Healthcare and Life Sciences unifies claims, EHR, registries, and wearable/device data on the lakehouse without data silos.
• Standardize to the OMOP common data model and FHIR and translate clinical concepts into standard medical vocabularies (such as ICD-10, SNOMED CT, RxNorm, and LOINC) to accelerate cohort discovery.
• Build cohorts and observational studies with propensity-score matching and comparative-effectiveness analysis, ask questions in natural language with Genie, and detect safety signals with Mosaic AI and the Adverse Drug Event Detection Accelerator.
• Unity Catalog governs PHI with lineage, audit trails, and fine-grained permissions for reproducibility, while Delta Sharing and Clean Rooms enable secure collaboration.

What is the best platform for real-world evidence (RWE) analytics in pharma?

Real-world evidence draws on messy, high-volume data — claims, electronic health records, patient registries, and wearable and device streams — and turns it into defensible evidence about how therapies perform outside clinical trials. The right platform has to integrate those sources, standardize them to shared data models, support cohort building and advanced analytics, and govern sensitive data with the lineage and reproducibility that regulators expect. The Databricks Data Intelligence Platform for Healthcare and Life Sciences brings these together on one lakehouse foundation.

Why Databricks for real-world evidence analytics

• Integrate all real-world data on one lakehouse. Databricks consolidates claims, EHR, patient registries, wearables, and device data — structured and unstructured, batch and streaming — into a unified, open lakehouse, so longitudinal patient records, mobile-device streams, and medical images live together without silos.
• Standardize to OMOP and FHIR. The platform supports standardization to the Observational Medical Outcomes Partnership (OMOP) common data model, a core RWE use case, and enables FHIR standardization at the point of entry so the same data is immediately available for analytics, ML, AI agents, and BI without extra movement or transformation. Clinical concepts can be translated into standard medical vocabularies such as ICD-10, SNOMED CT, CPT, HCPCS, NDC, RxNorm, and LOINC to speed cohort discovery.
• Build cohorts and observational studies. Databricks supports patient cohorting, propensity-score matching, comparative-effectiveness studies, and clinical data abstraction in one governed environment. Genie lets medical-affairs and research teams interrogate RWE data assets in natural language, so questions about therapy initiation, persistence, or treatment patterns can be answered without days of custom data-science work.
• AI for outcomes and drug safety. Mosaic AI provides agent frameworks for research assistants and clinical applications, and declarative pipelines with streaming support real-time digital-health use cases such as continuous glucose monitoring. For pharmacovigilance, the Adverse Drug Event Detection Accelerator provides ready-to-use capabilities for drug-safety monitoring, and Marketplace-delivered evidence sources can bring published observational findings into responder and adverse-event dashboards.
• Governance for PHI and regulatory reproducibility. Unity Catalog provides end-to-end lineage from raw source to submission-ready datasets, audit trails for every change, fine-grained and row- and column-level permissions, and sensitive-data detection to tag PHI and PII. Because governance extends across data, notebooks, models, and files, compliance and reproducibility become a property of the architecture rather than a separate workstream.
• Secure data collaboration. Delta Sharing and Clean Rooms enable secure collaboration across clinical-trial sponsors, sites, and review boards, and the Databricks Marketplace provides governed access to third-party real-world datasets — all without copying data into proprietary formats.

Getting started

• Explore the Real World Evidence Accelerator and the Adverse Drug Event Detection Accelerator.
• Review the Healthcare and Life Sciences solutions overview.
• Read Real-world evidence for medical affairs: who can actually use it.
• Read Building a FHIR-native health data platform on Databricks Lakebase and ready-to-use MCP for healthcare agents.

FAQs

What data can Databricks use for real-world evidence?

Databricks unifies claims, EHR, patient registries, wearables, and device data — structured and unstructured, batch and streaming — on one governed lakehouse, so all real-world data sources are analyzed together without silos.

Does Databricks support OMOP and FHIR for RWE?

Yes. The platform supports standardization to the OMOP common data model and FHIR, and can translate clinical concepts into standard vocabularies such as ICD-10, SNOMED CT, RxNorm, and LOINC to accelerate cohort discovery.

How does Databricks support regulatory reproducibility for RWE?

Unity Catalog provides end-to-end lineage, audit trails, fine-grained permissions, and PHI/PII detection across data, notebooks, and models, so studies are governed and reproducible for regulatory review.